The law of diminishing returns in clinical medicine: how much risk reduction is enough?
- PMID: 20453183
- DOI: 10.3122/jabfm.2010.03.090178
The law of diminishing returns in clinical medicine: how much risk reduction is enough?
Abstract
The law of diminishing returns, first described by economists to explain why, beyond a certain point, additional inputs produce smaller and smaller outputs, offers insight into many situations encountered in clinical medicine. For example, when the risk of an adverse event can be reduced in several different ways, the impact of each intervention can generally be shown mathematically to be reduced by the previous ones. The diminishing value of successive interventions is further reduced by adverse consequences (eg, drug-drug, drug-disease, and drug-nutrient interactions), as well as by the total expenditures of time, energy, and resources, which increase with each additional intervention. It is therefore important to try to prioritize interventions based on patient-centered goals and the relative impact and acceptability of the interventions. We believe that this has implications for clinical practice, research, and policy.
Comment in
-
Guest family physician commentaries.J Am Board Fam Med. 2010 May-Jun;23(3):283-4. doi: 10.3122/jabfm.2010.03.100051. J Am Board Fam Med. 2010. PMID: 20453173 No abstract available.
Similar articles
-
Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):216-23. doi: 10.1097/HJR.0b013e3282f335d0. Eur J Cardiovasc Prev Rehabil. 2008. PMID: 18391651
-
Primary prevention of myocardial infarction: putting the evidence to use.Arch Intern Med. 2010 Aug 9;170(15):1381-2. doi: 10.1001/archinternmed.2010.266. Arch Intern Med. 2010. PMID: 20696965 No abstract available.
-
Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.Am Heart J. 2009 Mar;157(3):509-516.e1. doi: 10.1016/j.ahj.2008.09.026. Epub 2008 Dec 17. Am Heart J. 2009. PMID: 19249422
-
AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.Expert Rev Cardiovasc Ther. 2004 Nov;2(6):891-902. doi: 10.1586/14779072.2.6.891. Expert Rev Cardiovasc Ther. 2004. PMID: 15500434 Review.
-
Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors?Eur Heart J. 1998 Oct;19 Suppl L:L15-21. Eur Heart J. 1998. PMID: 9821004 Review.
Cited by
-
On sustainability and low value care.Scand J Prim Health Care. 2024 Jun;42(2):235-236. doi: 10.1080/02813432.2024.2321525. Epub 2024 Feb 28. Scand J Prim Health Care. 2024. PMID: 38416128 Free PMC article. No abstract available.
-
Effect of a quality improvement intervention for management of preterm births on outcomes of all births in Kenya and Uganda: A secondary analysis from a facility-based cluster randomized trial.J Glob Health. 2022 Dec 29;12:04073. doi: 10.7189/jogh.12.04073. J Glob Health. 2022. PMID: 36580073 Free PMC article. Clinical Trial.
-
Failure of the Problem-Oriented Medical Paradigm and a Person-Centered Alternative.Ann Fam Med. 2022 Mar-Apr;20(2):145-148. doi: 10.1370/afm.2782. Ann Fam Med. 2022. PMID: 35346930 Free PMC article.
-
Is polypharmacy associated with mortality in the very old: Findings from the Newcastle 85+ Study.Br J Clin Pharmacol. 2022 Jun;88(6):2988-2995. doi: 10.1111/bcp.15211. Epub 2022 Jan 27. Br J Clin Pharmacol. 2022. PMID: 34981552 Free PMC article.
-
Effect of Individualized Preventive Care Recommendations vs Usual Care on Patient Interest and Use of Recommendations: A Pilot Randomized Clinical Trial.JAMA Netw Open. 2021 Nov 1;4(11):e2131455. doi: 10.1001/jamanetworkopen.2021.31455. JAMA Netw Open. 2021. PMID: 34726747 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources